Biocatalytic semi-artificial photosynthesis enables selective solar-to-chemical conversion by harnessing photoelectrocatalytic platforms to drive redox biocatalysis. However, the reliance of most photoelectrochemical (PEC)-based devices on transparent conductive oxides (TCOs) or wired configurations introduces resistive losses and architectural complexity, limiting the translation of biosolar conversion beyond laboratory-scale systems. Here, we report a wireless, monolithic semi-artificial leaf device toward scalable and practical solar biosynthesis. The PEC tandem, composed of a poly(ethylene glycol) (PEG)-modified BiVO4 (PEG:BiVO4) photoanode and a tunnel-oxide-passivated-contact (TOPCon) Si photovoltaic (PV), supplies sufficient photovoltage to reduce O2 to H2O2 on an anthraquinone-2-carboxylic acid (AQC)-functionalized carbon-fiber paper (CFP) cathode under solar light, sustaining over 100 h of stable operation. The photogenerated H2O2 reacts with peroxygenases to catalyze the oxyfunctionalization of substituted benzenes, alkanes, and fatty acids with record-high total turnover numbers of 166,100 (unspecific peroxygenase) and 3,700 (cytochrome P450). Furthermore, the scaling of the PEC device allows the direct conversion of natural light into enantiopure alcohols.
No takes yet. Share an insight, caveat, or question.
김민아 et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: